Literature DB >> 23115108

Hospital use, associated costs, and payer status for infants born with spina bifida.

Elizabeth Radcliff1, Cynthia H Cassell, Jean Paul Tanner, Russell S Kirby, Sharon Watkins, Jane Correia, Cora Peterson, Scott D Grosse.   

Abstract

BACKGROUND: Health care use and costs for children with spina bifida (SB) are significantly greater than those of unaffected children. Little is known about hospital use and costs across health insurance payer types. We examined hospitalizations and associated costs by sociodemographic characteristics and payer type during the first year of life among children with SB. We also examined changes in health insurance payer status.
METHODS: This study was a retrospective, statewide population-based analysis of infants with SB without anencephaly born in Florida during 1998-2007. Infants were identified by the Florida Birth Defects Registry and linked to hospital discharge records. Descriptive statistics on number of hospitalizations, length of stay, and estimated hospital costs per hospitalization and per infant were calculated during the first year of life. Results were stratified by selected sociodemographic variables and health insurance payer type.
RESULTS: Among 615 infants with SB, mean and median numbers of hospitalizations per infant were 2.4 and 2.0, respectively. Mean and median total days of hospitalization per infant were 25.2 and 14.0 days, respectively. Approximately 18% of infants were hospitalized more than three times. Among infants with multiple hospitalizations, 16.7% had a mix of public and private health insurance payers. Almost 60% of hospitalizations for infants were paid by public payer sources. Mean and median estimated hospital costs per infant were $39,059 and $21,937, respectively.
CONCLUSIONS: Results suggest a small percentage of infants with SB have multiple hospitalizations with high costs. Further analysis on factors associated with length of stay, hospitalizations, and costs is warranted.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23115108      PMCID: PMC4507424          DOI: 10.1002/bdra.23084

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  17 in total

1.  Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects.

Authors:  M A Honein; L J Paulozzi; T J Mathews; J D Erickson; L Y Wong
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

2.  Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.

Authors:  Laura J Williams; Cara T Mai; Larry D Edmonds; Gary M Shaw; Russell S Kirby; Charlotte A Hobbs; Lowell E Sever; Lisa A Miller; F John Meaney; Miriam Levitt
Journal:  Teratology       Date:  2002-07

3.  Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health.

Authors:  Scott D Grosse; Norman J Waitzman; Patrick S Romano; Joseph Mulinare
Journal:  Am J Public Health       Date:  2005-09-29       Impact factor: 9.308

4.  Preterm birth in pregnancies complicated by major congenital malformations: a population-based study.

Authors:  Stephanie E Purisch; Emily A DeFranco; Louis J Muglia; Anthony O Odibo; David M Stamilio
Journal:  Am J Obstet Gynecol       Date:  2008-09       Impact factor: 8.661

5.  Trends in the postfortification prevalence of spina bifida and anencephaly in the United States.

Authors:  Sheree L Boulet; Quanhe Yang; Cara Mai; Russell S Kirby; Julianne S Collins; James M Robbins; Robert Meyer; Mark A Canfield; Joe Mulinare
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2008-07

6.  Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002.

Authors:  Laura J Williams; Sonja A Rasmussen; Alina Flores; Russell S Kirby; Larry D Edmonds
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

7.  Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study.

Authors:  Mark A Canfield; Julianne S Collins; Lorenzo D Botto; Laura J Williams; Cara T Mai; Russell S Kirby; Kay Pearson; Owen Devine; Joe Mulinare
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2005-10

8.  Health care expenditures of children and adults with spina bifida in a privately insured U.S. population.

Authors:  Lijing Ouyang; Scott D Grosse; Brian S Armour; Norman J Waitzman
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2007-07

9.  Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-01-19       Impact factor: 17.586

Review 10.  Secondary conditions in children with disabilities: spina bifida as a case example.

Authors:  Rune J Simeonsson; Janey Sturtz McMillen; Gail S Huntington
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002
View more
  6 in total

1.  Modeling travel impedance to medical care for children with birth defects using Geographic Information Systems.

Authors:  Eric M Delmelle; Cynthia H Cassell; Coline Dony; Elizabeth Radcliff; Jean Paul Tanner; Csaba Siffel; Russell S Kirby
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-09-02

2.  Identifying Algorithms to Improve the Accuracy of Unverified Diagnosis Codes for Birth Defects.

Authors:  Jason L Salemi; Rachel E Rutkowski; Jean Paul Tanner; Jennifer L Matas; Russell S Kirby
Journal:  Public Health Rep       Date:  2018-04-05       Impact factor: 2.792

3.  Factors Associated with Travel Time and Distance to Access Hospital Care Among Infants with Spina Bifida.

Authors:  Elizabeth Radcliff; Eric Delmelle; Russell S Kirby; Sarah B Laditka; Jane Correia; Cynthia H Cassell
Journal:  Matern Child Health J       Date:  2016-01

Review 4.  Finding the genetic mechanisms of folate deficiency and neural tube defects-Leaving no stone unturned.

Authors:  Kit Sing Au; Tina O Findley; Hope Northrup
Journal:  Am J Med Genet A       Date:  2017-09-25       Impact factor: 2.802

Review 5.  Spinal Cord Injury in Myelomeningocele: Prospects for Therapy.

Authors:  Karolina Janik; Meredith A Manire; George M Smith; Barbara Krynska
Journal:  Front Cell Neurosci       Date:  2020-06-30       Impact factor: 5.505

6.  TRIM4 is associated with neural tube defects based on genome-wide DNA methylation analysis.

Authors:  Henan Zhang; Yi Guo; Hui Gu; Xiaowei Wei; Wei Ma; Dan Liu; Kun Yu; Wenting Luo; Ling Ma; Yusi Liu; Jia Xue; Jieting Huang; Yanfu Wang; Shanshan Jia; Naixuan Dong; Hongyan Wang; Zhengwei Yuan
Journal:  Clin Epigenetics       Date:  2019-02-01       Impact factor: 6.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.